Skip to content

DIVERSIFIED HEALTHCARE TRUST: 10-Q filed 2019-11-07

What DIVERSIFIED HEALTHCARE TRUST reported in its quarterly report filed 2019-11-07 (fiscal Q3 2019): 26 published measures, 85 facts as tagged in accession 0001075415-19-000030.

This filing

Form
10-Q (quarterly report)
Filed
2019-11-07
Fiscal period
fiscal Q3 2019
Accession
0001075415-19-000030 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All DIVERSIFIED HEALTHCARE TRUST filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-09-306,916,990,000USD
At 2018-12-317,160,426,000USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-09-303,948,768,000USD
At 2018-12-313,980,556,000USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-09-302,823,479,000USD
At 2018-12-313,023,112,000USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-09-3049,462,000USD
At 2018-12-3154,976,000USD
At 2018-09-3047,657,000USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-29,390,000USD92
2019-01-01 to 2019-09-30-36,537,000USD273
2018-07-01 to 2018-09-3045,805,000USD92
2018-01-01 to 2018-09-30405,415,000USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-09-30195,670,000USD273
2018-01-01 to 2018-09-30286,022,000USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2019-07-01 to 2019-09-30255,827,000USD92
2019-01-01 to 2019-09-30784,116,000USD273
2018-07-01 to 2018-09-30278,969,000USD92
2018-01-01 to 2018-09-30831,942,000USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-176,058,000USD273
2018-01-01 to 2018-09-30-314,294,000USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-26,234,000USD273
2018-01-01 to 2018-09-30136,943,000USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-09-302,104,259,000USD
At 2018-12-312,140,796,000USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2019-07-01 to 2019-09-30237,608,000shares92
2019-01-01 to 2019-09-30237,585,000shares273
2018-07-01 to 2018-09-30237,511,000shares92
2018-01-01 to 2018-09-30237,492,000shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2019-07-01 to 2019-09-30237,608,000shares92
2019-01-01 to 2019-09-30237,585,000shares273
2018-07-01 to 2018-09-30237,562,000shares92
2018-01-01 to 2018-09-30237,526,000shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-146,000USD92
2019-01-01 to 2019-09-30-47,000USD273
2018-07-01 to 2018-09-3079,000USD92
2018-01-01 to 2018-09-30444,000USD273

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-07-01 to 2019-09-3044,817,000USD92
2019-01-01 to 2019-09-30136,840,000USD273
2018-07-01 to 2018-09-3045,416,000USD92
2018-01-01 to 2018-09-30133,781,000USD273

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2019-09-30359,909,000USD
At 2018-12-31419,244,000USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2019-01-01 to 2019-09-30292,000USD273
2018-01-01 to 2018-09-30407,000USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-09-30237,900,277shares
At 2018-12-31237,729,900shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2019-09-3063,449,000USD
At 2018-12-3170,071,000USD
At 2018-09-30155,992,000USD
At 2017-12-3147,321,000USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2019-09-30-175,000USD
At 2018-12-31-266,000USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2019-09-302,968,222,000USD
At 2019-06-303,036,709,000USD
At 2019-03-313,113,438,000USD
At 2018-12-313,179,870,000USD
At 2018-09-303,394,480,000USD
At 2018-06-303,443,573,000USD
At 2018-03-313,416,117,000USD
At 2017-12-313,277,188,000USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-27,946,000USD92
2019-01-01 to 2019-09-30-32,258,000USD273
2019-04-01 to 2019-06-30-35,816,000USD91
2019-01-01 to 2019-03-3131,504,000USD90
2018-07-01 to 2018-09-3047,202,000USD92
2018-01-01 to 2018-09-30409,596,000USD273
2018-04-01 to 2018-06-30124,988,000USD91
2018-01-01 to 2018-03-31237,405,000USD90

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-29,436,000USD92
2019-01-01 to 2019-09-30-36,446,000USD273
2018-07-01 to 2018-09-3045,978,000USD92
2018-01-01 to 2018-09-30405,505,000USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-309,604,000USD92
2019-01-01 to 2019-09-3028,287,000USD273
2018-07-01 to 2018-09-3031,032,000USD92
2018-01-01 to 2018-09-3085,228,000USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-01-01 to 2019-09-30219,522,000USD273
2018-01-01 to 2018-09-30214,300,000USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2019-07-01 to 2019-09-3073,368,000USD92
2019-01-01 to 2019-09-30219,522,000USD273
2018-07-01 to 2018-09-3071,661,000USD92
2018-01-01 to 2018-09-30214,300,000USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2019-01-01 to 2019-09-30129,010,000USD273
2018-01-01 to 2018-09-30112,462,000USD273

Inspect the source

Entity
DIVERSIFIED HEALTHCARE TRUST / CIK 0001075415
Captured
2026-09-20T05:20:10.749Z
SEC response SHA-256
8898f1539f403516574ac52f0720ed5518196148c88e53b7d3b2e881631ea620

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001075415.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))